Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human/Mouse/Rat Calcineurin A Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB2839SP
This item is not returnable.
View return policy
Description
Calcineurin A Monoclonal specifically detects Calcineurin A in Human, Mouse, Rat samples. It is validated for Western Blot.Specifications
Calcineurin A | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL | |
calcineurin A alpha, Calmodulin-dependent calcineurin A subunit alpha isoform, CALN, CALNA, CALNAcatalytic subunit, alpha isoform, CAM-PRP catalytic subunit, CNA, CNA1, CNA1CALNA1, EC 3.1.3.16, PP2B, PP3CA, PPP2B, PPP2BCCN1, PPP3CA, protein phosphatase 2B, catalytic subunit, alpha isoform, protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform(calcineurin A alpha), protein phosphatase 3, catalytic subunit, alpha isozyme, serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
5530 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Western Blot | |
302202 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
PPP3CA | |
Bovine brain Calcineurin holoenzyme (A and B subunits) | |
25 μg | |
Primary | |
Detects human, mouse, and rat Calcineurin A. | |
Human, Mouse, Rat | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction